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a b s t r a c t
Ethnopharmacological relevance: Croton campestris A. St.-Hill., popularly known as “velame do campo”, is
a species native from savannah area of Northeast Brazil, which is used by traditional communities in folk
medicine for a variety of health problems, especially detoxiﬁcation, inﬂammation and gastritis. The
present study investigates the possible gastric antiulcer activity of Croton campestris root extract (CCRE)
and mechanisms of action underlying this effect.
Materials and methods: Gastric lesions were induced in mice by ethanol, acidiﬁed ethanol and
indomethacin. CCRE was previously administered orally in doses ranging from 50 to 750 mg/kg. Stomach
lesions were measured. The involvement of Nitric Oxide (NO), prostaglandins (PGEs), ATP-dependent Kþ
channel and adrenergic receptor was investigated through speciﬁc inhibitors.
Results: CCRE produced signiﬁcant antiulcer activity against absolute ethanol, acidiﬁed ethanol and
indomethacin induced gastric lesions. The pretreatment with L-NAME (10 mg/kg, p.o.), an inhibitor of
nitric oxide synthesis and indomethacin (10 mg/kg, s.c.), an inhibitor of prostaglandin production,
reversed the antiulcer action of CCRE.
Conclusion: Taking together, these results suggest that the antiulcer activity of CCRE is dependent of NO
and prostaglandin pathways possibly due to its ability to stimulate the synthesis of NO, and activation of
endogenous prostaglandin production. Therefore, the use of CCRE in traditional Brazilian medicine
against gastric disorders has a scientiﬁc basis.
& 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
A peptic ulcer consists in a gastric and duodenal mucosa
disorder with chronic and recurring character, caused by the
acidity of gastric secretion. It has been for more than a century
the major cause of surgery (Yuan et al., 2006) and still a common
global problem with increasing morbidity and mortality rates. An
imbalance between protective factors (mucus and bicarbonate
secretion, increased levels of antioxidants and production of
prostaglandins) and mucosal aggressors (stress, ethanol exposure,
smoking and frequent ingestion of non-steroidal anti-inﬂamma-
tory drugs (NSAIDs) have been associated with the etiology of
peptic ulcer (Dursun et al., 2009; Falcão et al., 2008; Tarnawski
et al., 2012). For instance, ethanol consumption can cause gastric
damage due to the generation of reactive oxygen species (ROS),
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decreased cell proliferation and exacerbated inﬂammatory
response (Choi et al., 2009; Ineu et al., 2008).
Nitric oxide (NO) plays a major role in the regulation of gastric
acid secretion and modulation of gastric mucosal integrity
together with endogenous prostaglandins (Khalifa et al., 2002;
Taha et al., 2012). In upper gastrointestinal tract (GI), NO acts as a
potent vasodilator known to increase gastric mucosa blood ﬂow,
regulates the secretion of mucus and bicarbonate, inhibits the
gastric secretion and protects the gastric mucosa against the
damage induced by a variety of damaging agents and corrosive
substances (Tarnawski et al., 2013). However, inhibition of NO
synthase by L-NAME has been reported to aggravate the injury in
animal model of gastric ulcer (Konturek et al., 1993). Similarly, a
disruption in the synthesis of cytoprotective prostaglandins (PGE2
and PGI2) by inhibition of the constitutive form of cyclooxygenase
(COX-1) in the mucous is considered one of the main mechanisms
of the formation of peptic ulcers and duodenal disorders
(Hoogerwerf and Pasricha, 2006).
Various synthetic compounds are commercially available for the
treatment of pectic ulcer; but, they are costly and many of them are
associated with side effects when used at long term (Bandyopadhyay
et al., 2002; DeVault and Talley, 2009; Waldum et al., 2005). Hence,
the search for new potentially agents through natural sources with
no or reduced sides effects that possess antioxidant and antiulcero-
genic properties is of utmost importance.
Croton campestris A. St-Hill (Euphorbiaceae), popularly known
as “velame do campo”, is a species native from savannah area of
Northeast Brazil. Infusions of the leaves and roots of the plant in
alcoholic beverages and teas, are used in Brazilian folk medicine
for gastric, hematological and inﬂammatory disturbances, as well
as respiratory problems. Substantial evidence from the literature
indicate that Croton campestris displays antibacterial (Coutinho
et al., 2011; De Almeida et al., 2013), antibiotic (De Almeida et al.,
2013; Matias et al., 2011), molluscicidal (El Babili et al., 2006) and
anti-inﬂammatory properties (Falcão et al., 2005), which might be
due to its antioxidant activity. Recently, our research group
reported the antiulcerogenic activity of the leaves extracts of
Croton campestris (Brito Júnior et al., 2013). However, the possible
mechanism by which Croton campestris exerts this action was not
clearly understood.
Considering that there is a scarcity of scientiﬁc evidence of the
pharmacological effect of Croton campestris that may justify its
traditional use on the gastrointestinal system, the present study
was undertaken to investigate the possible antiulcerogenic effects of
Croton campestris root extract in different experimental models of
gastric ulcer induction, including ethanol, acidiﬁed ethanol and
indomethacin. In addition the possible mechanisms underlying its
action were investigated. The results indicated that Croton campestris
showed signiﬁcant gastroprotective action in all models of induced-
gastric ulcer without altering intestinal motility in mice, with
involvement of nitric oxide (NO) and prostaglandins pathway.
2. Materials and methods
2.1. Chemicals and apparatus
All chemicals used including solvent, were of analytical grade.
Hydrochloric acid (HCL) (PubChem CID:313), atropine (PubChem
CID:174174), absolute ethanol (PubChem CID:701), glyburide
(PubChem CID:3488), indomethacin (PubChem CID:3715), yohim-
bine (PubChem CID:8969), L-Arginine (PubChem CID:9322), mis-
oprostol (PubChem CID:5282381) and N-nitro-L-arginine metyl
ester (L-NAME) (PubChem CID:39836) were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). For HPLC analysis, acetonitrile
(PubChem CID: 6342), formic acid (PubChem CID: 284), gallic acid
(PubChem CID: 370), chlorogenic acid (PubChem CID: 1794427)
and caffeic acid (PubChem CID: 689043) were purchased from
Merck (Darmstadt, Germany). Quercetin (PubChem CID: 5280805),
quercitrin (PubChem CID: 5280459), isoquercitrin (PubChem CID:
5280804), rutin (PubChem CID: 5280805), catechin (PubChem
CID: 9064), epicatechin (PubChem CID: 72276) and kaempferol
(PubChem CID: 5280863) were acquired from Sigma Chemical Co.
(St. Louis, MO, USA). High performance liquid chromatography
(HPLC–DAD) was performed with the HPLC system (Shimadzu,
Kyoto, Japan), Prominence Auto Sampler (SIL-20A), equipped with
Shimadzu LC-20AT reciprocating pumps connected to the degasser
DGU 20A5 with integrator CBM 20A, UV–VIS detector DAD (diode)
SPD-M20A and Software LC solution 1.22 SP1.
2.2. Plant material and extract preparation
The roots of Croton campestris were collected from the munici-
pality of Crato, Ceara, Brazil, (712202.8″S; 39128042.4″W; altitude:
892 m above sea level) in January, 2011. The plant material was
identify at the Herbarium of the Federal University of Rio Grande
do Norte—UFRN, where a voucher specimen was deposited
(#7095). Fresh roots of C. campestres (3200 g) were washed under
running water, and air dried. The air dried materials were
macerated with 8.7 l of 99.9% ethanol and water (1:1, v/v) for
seven days. The mixture was ﬁltered using ﬁltered paper and the
solvent was evaporated and lyophilized to obtain 160 g of hydro-
alcoholic Croton campestris root extract (CCRE) (Matos, 1997).
2.3. Chemical proﬁle
The hydroalcoholic extract of roots of Croton campestris was
subjected to a phytochemical screening for detecting the presence
of tannins, saponins, ﬂavonoids, steroids, triterpenes, cumarins,
quinones, organic acids and alkaloids according to the method
described by Matos (1997) and modiﬁed by Brito Júnior et al.
(2013).
2.4. Qualitative and quantitative analyses of phenolics and
ﬂavonoids compounds by HPLC–DAD
Reverse phase chromatographic analyses were carried out
under gradient conditions using C18 column (4.6 mm250 mm)
packed with 5 μm diameter particles. The mobile phase was water
containing 1% formic acid (A) and acetonitrile (B), and the
composition gradient was: 13% of B until 10 min and changed to
obtain 20%, 30%, 50%, 60%, 70%, 20% and 10% B at 20, 30, 40, 50, 60,
70 and 80 min, respectively (Boligon et al., 2012) with slight
modiﬁcations. Hydroalcoholic extract of Croton campestris was
dissolved in ethanol at a concentration of 2 mg/ml. The presence
of ten antioxidants compounds was investigated, namely, gallic
acid, chlorogenic acid, caffeic acid, catechin, epicatechin, quercetin,
isoquercitrin, quercitrin, rutin and kaempferol. Identiﬁcation of
these compounds was performed by comparing their retention
time and UV absorption spectrum with those of the commercial
standards. The ﬂow rate was 0.7 ml/min, injection volume 40 μl
and the wavelength were 254 nm for gallic acid, 280 nm for
catechin and epicatechin, 325 nm for caffeic and chlorogenic acids,
and 365 nm for quercetin, isoquercitrin, quercitrin, rutin and
kaempferol. All the samples and mobile phase were ﬁltered
through 0.45 μm membrane ﬁlter (Millipore) and then degassed
by ultrasonic bath prior to use. Stock solutions of standards
references were prepared in the HPLC mobile phase at a concen-
tration range of 0.030–0.250 mg/ml for kaempferol, quercetin,
isoquercitrin, quercitrin, catechin, epicatechin and rutin; and
0.030–0.250 mg/ml for gallic, caffeic and chlorogenic acids. The
chromatography peaks were conﬁrmed by comparing its retention
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time with those of reference standards and by DAD spectra (200 to
500 nm). Calibration curve for gallic acid: Y¼13629xþ1195.8
(r¼0.9993); catechin: Y¼12407xþ1259.6 (r¼0.9997); epicatechin
(Y¼12583xþ1195.6 (r¼0.9995); caffeic acid: Y¼11758xþ1359.2
(r¼0.9996); chlorogenic acid: Y¼14061xþ1325.3 (r¼0.9995);
rutin: Y¼12845þ1065.7 (r¼0.9999); quercetin: Y¼13560xþ
1192.6 (r¼0.9991); isoquercitrin: Y¼12507xþ1304.2 (r¼0.9997);
quercitrin: Y¼13478xþ1359.5 (r¼0.9994) and kaempferol:
Y¼14253xþ1238.9 (r¼0.9997). All chromatography operations
were carried out at ambient temperature and in triplicate. The
limit of detection (LOD) and limit of quantiﬁcation (LOQ) were
calculated based on the standard deviation of the responses and
the slope using three independent analytical curves. LOD and LOQ
were calculated as 3.3 and 10s/S, respectively, where s is the
standard deviation of the response and S is the slope of the
calibration curve (Boligon et al., 2013).
2.5. Animals
Male and female albino mice, strain Swiss, weighing 20–30 g
from our own breeding colony (Animal House-holding, UFRN,
Brazil) were kept in cages with free access to foods and water, in
a room with controlled temperature (22–24 1C) and in 12 h light/
dark cycle. The mice were divided into groups of six animals each,
acclimatized and accustomed to the laboratory atmosphere for at
least a week before the experiments and were used only once
throughout the experiment. The protocol of this study has been
approved by the Ethics Committee on Animal Research of the
Faculty of Medicine of Juazeiro do Norte—FMJ, Brazil, with number
271 610 2009_0432_FR. The number of animals and intensity of
ulcerogenic agents were the minimum necessary to demonstrate
consistent treatment effects.
2.6. Experimental procedures
2.6.1. Assessment of oral/intraperitoneal acute toxicity
Preliminary studies were carried out with a small number of both
genders of animals, where they received different concentrations
(17.5–5000 mg/kg) of hydroalcoholic extract of roots of Croton
campestris (CCRE) orally and intraperitoneally. A single dose of
extract was administered and periodic monitoring was conducted
for 14 days. Our objective was to choose the less toxic route of
administration and to determine the duration of the exposure. It
should be stressed that the animals were fasted for 14 h prior
administration. The results demonstrated that animals that received
oral administration did not present weight alteration when compare
with the control animal and no signs of morbidity and death was
registered. The median lethal dose (LD50) for oral administration of
CCRE was higher or equal to 2000 mg/kg, with a conﬁdence interval
of 95% (data not shown). However, intraperitoneal administration of
CCRE at dose of 2000 mg/kg presented lethargy, diarrhea, tremors
and death after 24 h of treatment. Therefore, for the determinative
studies, we used oral administration of CCRE (50–750 mg/kg) and
30 min of treatment (OECD, 2008).
2.6.2. Gastric lesions induced by ethanol
Ethanol-induced gastric lesion was carried out according to
Robert et al. (1979). The mice were divided into eight groups of
6 animals per group (3 males and 3 females), fasted for a period of
14 h and treated with CCRE (50, 75, 125, 250, 500 and 750 mg/kg,
p.o.), omeprazole (30 mg/kg, p.o.), or vehicle (saline, 0.1 ml/10 g,
p.o.) 1 h before administration of absolute ethanol (0.1 ml/10 g,
p.o.). After 30 min, the animals were sacriﬁced by cervical disloca-
tion. Their stomach was removed, opened along the greater
curvature, rinsed with saline and digitized; the ulcerated area
was expressed as a percentage relative to the total area of the
gastric body using ImageJ software.
2.6.3. Gastric lesions induced by acidiﬁed ethanol
This test was performing according to Mizui et al. (1987). The
mice were treated with CCRE (50, 75, 125, 250, 500 and 750 mg/
kg, p.o.), omeprazole (30 mg/kg, p.o.), or vehicle (saline, 0.1 ml/
10 g, p.o. for the control lesion group). One hour after treatment,
the animals received 0.2 ml of 0.3 M hydrochloric acid (HCl) in 60%
ethanol and were sacriﬁced 1 h later. The percentage of stomach
ulceration was determined as described above.
2.6.4. Gastric lesions induced by indomethacin
The induction of gastric lesions by indomethacin was per-
formed as described by Djahanguiri (1969). The mice were
pretreated with CCRE (250, 500 and 750 mg/kg, p.o.), omeprazole
(30 mg/kg, p.o.), or vehicle (saline, 0.1 ml/10 g, p.o. for the control
lesion group). Six hours after administration of the ulcerogenic
agent (indomethacin, 10 mg/kg, s.c), the animals were sacriﬁced.
The percentage of stomach ulceration was determined as
described above.
2.6.5. Evaluation of the mechanisms involved in gastroprotective
activity of CCRE
In order to investigate the possible mechanisms by which CCRE
exerts its gastroprotective effect, we examined the involvement of
α-2 receptors, prostaglandins, nitric oxide and ATP-dependent
Kþ channel activation. For this set of experiments, we used 75 mg/
kg, of CCRE since it did not present toxicity and was effective in
decreasing the induced damage in all the experimental models of
gastric ulcer. To evaluate the involvement of different targets, it was
used speciﬁc antagonists such as yohimbine (2 mg/kg, i.p.) for alfa (α)
2 adrenergic receptor, indomethacin (10 mg/kg, p.o.) for prostaglan-
dins, L-NAME (10 mg/kg, i.p.) for NO synthesis and glibenclamide
(5 mg/kg, p.o.) for ATP-dependent Kþ channel or speciﬁc agonists as
L-arginine (600 mg/kg, p.o.) as a positive control for L-NAME and
misoprostol (0.016 mg/kg, p.o.) as a control for indomethacin. All
drugs were dissolved in saline solution.
In each case, the animals were pretreated with the speciﬁc
antagonist or agonist for 30 min before the administration of
CCRE. The volume of 0.1 ml/10 g, p.o. of 96% ethanol was orally
administered one hour after CCRE. The animals were then sacri-
ﬁced, and their stomach was removed, opened along the greater
curvature, washed in saline and compressed between glass slides
for better viewing. The slides were scanned at 1200 dpi. The
percentage of area with gastric lesions (glandular portion) was
determined with ImageJ software. The injured area was expressed
as a relative percentage of the total area of the gastric body
(Djahanguiri, 1969, Rahgozar et al., 2001).
2.6.6. Effect of CCRE on intestinal motility
The effect of CCRE on intestinal motility was evaluated as
reported by Lapa et al. (2008). Brieﬂy, animals were treated with
CCRE (75 mg/kg, p.o.), saline (0.1 ml/10 g, vehicle, p.o.), or atropine
(0.01 g/kg, p.o.) a muscarinic antagonist, followed by 10% activated
charcoal one hour after (0.1 ml/10 g, p.o.). Thirty minutes after
charcoal administration, the animals were sacriﬁced, and their
small intestine was removed. The total length of the intestine
(the pyloric region to the ileocecal junction) was then measured;
the distance traveled by the charcoal was determined based on the
distance from the pylorus to the last portion of the intestine that
contained at least 1 cm of continuous charcoal.
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2.7. Statistical analysis
Results were expressed as mean7standard error mean (S.E.M.)
and analyzed by one-way ANOVA followed by Newman–Keuls test,
unless otherwise stated. po0.05 was considered signiﬁcant.
Graphs were drawn by using GraphPad Prism 5 software.
3. Results
3.1. Chemical proﬁle
Phytochemical prospecting of CCRE identiﬁed the presence of a
variety of compounds including phenols, ﬂobabenic tannins,
ﬂavones, ﬂavonols, xanthones, ﬂavanonols, ﬂavonone, alkaloids
and terpenes.
3.2. HPLC analysis
HPLC ﬁngerprinting of CCRE revealed the presence of the gallic
acid (tR¼10.07 min; peak 1), catechin (tR¼16.78 min; peak 2);
chlorogenic acid (tR¼20.15 min; peak 3), caffeic acid (tR¼
24.93 min; peak 4), epicatechin (tR¼34.17 min; peak 5), rutin
(tR¼38.24 min; peak 6), quercitrin (tR¼42.59 min; peak 7), iso-
quercitrin (tR¼45.02 min; peak 8), quercetin (tR¼50.11 min; peak
9) and kaempferol (tR¼59.85 min; peak 10) (Fig. 1 and Table 1).
They were identiﬁed by comparisons to the retention times and
UV spectra of authentic standards analyzed under identical analy-
tical conditions.
3.3. Induction of gastric-lesions
3.3.1. Effect of CCRE on gastric lesions induced by absolute ethanol
The effects of CCRE on gastric lesions induced by absolute
ethanol (0.1 ml/10 g, p.o.) are shown in Fig. 2. The animals that
received only vehicle combined with oral administration of
absolute ethanol showed an extensive area of gastric lesion
(18.5772.12%). Whereas, oral administration of CCRE (50–
750 mg/kg) before ethanol, produced a marked reduction in the
damaged area, when compared to the control (po0.001, Fig. 2B).
The highest reduction of gastric lesion was obtained at concentra-
tion 750 mg/kg. The percentage of reduced gastric lesions by CCRE
varied from 95.79% (50 mg/kg) to 99.03% (750 mg/kg), when
compared to the control (po0.001). Similar to that observed with
CCRE, omeprazole (30 mg/kg, p.o.) used as positive control, sig-
niﬁcantly reduced the ulcerated area by 96.23% when compared to
the control (po0.001). However, the reduction was more pro-
nounced with CCRE at 75 mg/kg and 750 mg/kg, in comparison to
omeprazole used as standard (Fig. 2B).
3.3.2. Gastric lesion induced by acidiﬁed ethanol
A second model of gastric lesion was induced by acidiﬁed
ethanol (0.1 ml/10 g, p.o.). The animals that received only vehicle
combined with oral administration of acidiﬁed ethanol showed an
extensive area of gastric lesion (23.1973.09%). However, pre-
treatment with CCRE for 1 h reduced substantially the damaged
Fig. 1. Representative high performance liquid chromatography proﬁle of Croton
campestris, detection UV was at 325 nm. Gallic acid (peak 1), catechin (peak 2),
chlorogenic acid (peak 3), caffeic acid (peak 4), epicatechin (peak 5), rutin (peak 6),
quercitrin (peak 7), isoquercitrin (peak 8), quercetin (peak 9) and kaempferol (peak
10). Chromatographic conditions are described in Section 2.
Table 1
Quantiﬁcation of some phenolics and ﬂavonoids from CCRE.
Compounds Croton campestris LOD
(μg/ml)
LOQ
(μg/ml)
(mg/g) (%)
Gallic acid 11.7970.02a 1.17 0.024 0.079
Catechin 5.6070.01b 0.56 0.007 0.023
Chlorogenic acid 20.5170.03c 2.05 0.013 0.042
Caffeic acid 17.8270.03d 1.78 0.035 0.115
Epicatechin 3.1970.01e 0.31 0.008 0.027
Rutin 7.9570.03f 0.79 0.042 0.138
Quercitrin 23.4870.01c 2.34 0.019 0.063
Isoquercitrin 6.2770.01b 0.62 0.032 0.104
Quercetin 17.3070.03d 1.73 0.028 0.092
Kaempferol 6.1570.02b 0.61 0.015 0.049
Results are expressed as mean7standard deviations (SD) of three determinations.
Averages followed by different letters differ by Tukey test at po0.001.
Fig. 2. Effect of oral administration of the CCRE on gastric lesions induced by
absolute ethanol in mice. (A) Macroscopic appearance of the mice stomach with
ethanol-induced gastric lesions: Control group (a) ethanol treated group (b) CCRE
50 mg/kg and 250 mg/kg followed by ethanol treated groups ((c) and (d),
respectively). (B) Quantiﬁcation of ulcerated area expressed in %. nnnpo0.001
when compared with control group (CL).
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area caused by acidiﬁed ethanol, at all the concentrations tested
(50–750 mg/kg), when compared to the control (po0.001, Fig. 3).
The positive control for lesion inhibition, omeprazole (30 mg/kg,
p.o.), reduced signiﬁcantly the gastric ulcer lesions by 88.09%,
when compared to the control (po0.001). But the reduction
obtained with the standard omeprazole, was lower than that
observed with CCRE (75–750 mg/kg) (Fig. 3B).
3.3.3. Effect of CCRE on gastric lesions induced by indomethacin
The effects of CCRE on gastric lesions induced by indomethacin
(10 mg/kg, s.c.) are shown in Fig. 4. Administration of indometha-
cin (10 mg/kg, s.c.) induced a large area of gastric lesion
(16.6171.69%). Pre-treatment with CCRE (250–750 mg/kg) for
6 h signiﬁcantly reduced the intensity of indomethacin-induced
gastric lesions in a similar manner as does omeprazole (30 mg/kg,
p.o.), when compared to the control (po0.001, Fig. 4B). Interest-
ingly, CCRE at concentration 750 mg/kg exhibited the highest the
reduction of lesions.
3.4. Mechanisms of action
To investigate the possible mechanisms by which CCRE exerts
its antiulcerogenic activity, we used the concentration of 75 mg/kg
that generally presented the highest reduction in ulcer lesions in
all the experimental models of gastric ulcer used. Only ethanol-
induced gastric lesion was used for this set of experiments.
3.4.1. Involvement of nitric oxide (NO) pathway
The possible role of nitric oxide (NO) in the gastroprotective
effect of CCRE was investigated and the results are presented in
Fig. 5. Animals that received L-NAME (10 mg/kg, i.p.), an inhibitor
of the enzyme Nitric Oxide Synthase (NOS), prior to absolute
Fig. 3. Effect of oral administration of the CCRE on gastric lesions induced by acid
ethanol in mice. (A) Macroscopic appearance of the mice stomach with acid
ethanol-induced gastric lesions: Control group (a) acid ethanol treated group
(b) CCRE 50 mg/kg and 250 mg/kg followed by ethanol treated groups ((c) and
(d), respectively). (B) Quantiﬁcation of ulcerated area expressed in %. nnnpo0.001
when compared with control group (CL).
Fig. 4. Effect of oral administration of the CCRE on gastric lesions induced by
indomethacin in mice. (A) Macroscopic appearance of the mice stomach with
indomethacin-induced gastric lesions: Control group (a) indomethacin treated
group (b) CCRE 250 mg/kg and 750 mg/kg followed by indomethacin treated
groups ((c) and (d), respectively). (B) Quantiﬁcation of ulcerated area expressed
in %. nnnpo0.001 when compared with control group.
Fig. 5. Involvement of nitric oxide (NO) in the gastroprotective effect of the CCRE in
gastric lesions model induced by absolute ethanol in mice. Signiﬁcance apo0.001
versus L-NAME (10 mg/kg, p.o.), bpo0.001 versus control (CL), and cpo0.001
versus L-NAME (10 mg/kg, p.o.)þCCRE (75 mg/kg, p.o.).
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ethanol administration (0.1 ml/10 g, p.o.) showed a large percen-
tage of ulcerated area (39.5676.41%) when compared to control
(21%) (Fig. 5). However, animals that received L-arginine (600 mg/
kg, p.o.) in combination with absolute ethanol exhibited remark-
able reduction in the injured area (1.4770.38%), with percentage
of ulcer reduction of 92.74% (Fig. 5, po0.001). CCRE (75 mg/kg,
p.o.) produced a signiﬁcant reduction in ulcerated area to
1.7071.41% with a percentage reduction of 91.71% when com-
pared to the control (po0.001). In contrast, when L-NAME was co-
administered with CCRE, this effect was not observed. This result
strongly suggests that the gastroprotective effect of CCRE may be
due to its ability to stimulate nitric oxide synthase (NOS).
3.4.2. Involvement of prostaglandin pathway
In addition, it was investigated the possible participation of
prostaglandins in the protective effect of CCRE against gastric lesions
induced by absolute ethanol. As it can be seen in Fig. 6, oral
administration of absolute ethanol induced a gastric lesion area of
13.0971.92%. Animals that received indomethacin (10 mg/kg, s.c.)
and absolute ethanol (0.1 ml/10 g, p.o.) displayed a slight increase of
the ulcerated area (14.8671.99%). However, animals that received
misoprostol (0.016 mg/kg, p.o.) combined with absolute ethanol
showed dramatic reduction in the injured area (0.5770.25%), with
a percentage reduction of 95.64% (Fig. 6). CCRE (75 mg/kg, p.o.)
exhibited a signiﬁcant (po0.001) reduction in the ulcerated area
(0.2970.16%) with 97.78% reduction, when compared to control
(Fig. 6). In contrast however, co-administration of CCRE (75 mg/kg,
p.o.) and indomethacin (10 mg/kg, s.c.) did not change the ulcerated
area (13.8670.79%) when compared to the control (13.0971.92%)
(Fig. 6), suggesting that the gastroprotective mechanism of CCRE
may be associated with its capacity to activate endogenous
prostaglandins.
3.4.3. Involvement of α2-noradrenergic receptor pathway
In parallel, it was investigated the possible involvement of
alpha-2 noradrenergic receptor in the protective effect of CCRE
against gastric lesions induced by absolute ethanol. As shown in
Fig. 7, animals that received only vehicle combined with oral
administration of absolute ethanol showed a gastric lesion area of
(22.1672.17%) (Fig. 7). In addition, animals that received yohimbine
(2 mg/kg, i.p.) together with absolute ethanol (0.1 ml/10 g, p.o.)
exhibited an extensive ulcerated area of (27.0372.87%). CCRE
(75 mg/kg, p.o.) produced a dramatic reduction (po0.001) in ulcer-
ated area (from 22.1672.17% to 1.7071.41%) with a percent reduc-
tion of 92.32%. However, co-administration of CCRE (75 mg/kg, p.o.)
with yohimbine (2 mg/kg, i.p.) still exerted a signiﬁcant gastroprotec-
tive effect (3.6870.57%, po0.001) with 83.39% reduction in the
ulcerated area (Fig. 7).
3.4.4. Involvement of ATP-dependent Kþ channels pathway
In the evaluation of the possible involvement of ATP-dependent
Kþ channels in the protective effect of CCRE against gastric lesions
induced by absolute ethanol, it was observed that mice that
received only vehicle in combination with oral administration of
absolute ethanol displayed a gastric lesion area of (23.8572.74%)
(Fig. 8). Mice that received glibenclamide (5 mg/kg, i.p.) along with
absolute ethanol (0.1 ml/10 g, p.o.) showed an ulcerated area of
(20.5472.57%). CCRE (75 mg/kg, p.o.) produced a signiﬁcant
(po0.001) reduction in ulcerated area (from 23.8572.74% to
0.2970.16%) with 98.78% reduction when compared to the control
(Fig. 8). CCRE (75 mg/kg, p.o.) when given with glibenclamide
(5 mg/kg, i.p.) still exerted a signiﬁcant gastroprotective effect
(po0.001) with a percentage of ulcerated area of 4.9470.46%
(i.e., 79.28% reduction) (Fig. 8).
3.5. Evaluation of CCRE administration on intestinal motility
The percentage of the distance traveled by the marker
(activated charcoal) in the small intestine of control mice was
Fig. 6. Involvement of prostaglandins in the gastroprotector effect of the CCRE in
gastric lesions model induced by absolute ethanol in mice. Signiﬁcance apo0.001
versus Indomethacin (10 mg/kg, s.c.), bpo0.001 versus control (CL).
Fig. 7. Involvement of noradrenergic receptor alfa 2 in the gastroprotector effect of
the CCRE on gastric lesions model induced by absolute ethanol in mice. Signiﬁcance
apo0.001 versus yohimbine (2 mg/kg, i.p.) and bpo0.001 versus control (CL).
Fig. 8. The role of ATP-dependent Kþ channels in the gastroprotector effect of the
CCRE in gastric lesions model induced by absolute ethanol in mice. Signiﬁcance
apo0.001 versus glibenclamide (2 mg/kg, p.o.), bpo0.001 versus control (CL).
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(83.2773.70%). Mice that received oral administration of CCRE
(75 mg/kg) had a distance traveled by the marker (74.9973.47%)
similar to that obtained in the control (vehicle group), suggesting
that CCRE did not affect gastrointestinal motility. In contrast, when
atropine, a muscarinic antagonist, was administered (0.01 g/kg, p.
o.), the intestinal motility signiﬁcantly decrease to (60.4571.26%),
when compared to the control (po0.001, Fig. 9).
4. Discussion
Medicinal plants used in folk medicine have been reported to
exert a variety of beneﬁcial effects including neuroprotection and
gastroprotection. In the present study, we provide scientiﬁc
evidence for the traditional use of Croton campestris in the
treatment of gastric ulcers. Our results demonstrated for the ﬁrst
time that Croton campestris exerts gastroprotective properties
against ethanol-, acidiﬁed ethanol-, and indomethacin-induced
gastric lesions, and that this effect seems to be mediated via
stimulation of NO and activation of endogenous prostaglandins.
Several molecular mechanisms that participate in the mucosal
protection action have been proposed. They include the biosynth-
esis and release of Nitric Oxide (NO), prostacyclin (PGI2), prosta-
glandin E2 (PGE2) and Carbon Monoxide (CO). These endothelial
mediators act by reducing the activation of platelets and leuko-
cytes, preventing thrombus formation, promoting thrombolysis,
maintaining tissue perfusion and microvascular wall protecting
against acute damage. This function is essential for mucosal
defense because the decrease in blood ﬂow through mechanical
restriction leads to the development of hemorrhagic necrosis
(Tarnawski et al., 2012).
In this study, previous administration of NOS inhibitor,
L-NAME, blocked the protective effect of CCRE against lesion
induced by absolute ethanol, while treatment with NOS substrate,
L-arginine, did not interfere with CCRE protective activity. This
data depicts the involvement of NO pathway in anti-ulcerogenic
potential of Croton campestris. In fact, NO is a putative messenger
and gas, which participates in the signal transduction related to a
variety of physiological process such as smooth muscle relaxation
and vasodilation, neurotransmission, regulation of pro- and anti-
apoptotic mechanisms, and control of blood pressure and blood
ﬂow (Szlachcic et al., 2013). It is also implicated in controlling
gastrointestinal motility, gastric blood ﬂow, recruitment of neu-
trophils and secretion of mucus (Kubes et al., 1991). The enzymatic
biosynthesis of NO and its bioavailability is mainly controlled by
the expression and activity of NOS (Szlachcic et al., 2013).
Prostaglandins (PGs) play an important role in the maintenance
of mucosal integrity whose biosynthesis in the gastrointestinal
tract is exclusively catalyzed by COX-1, whereas, COX-2 mainly
yields PGs in pathophysiological reactions such as inﬂammation
(Peskar, 2001). It is known that prostaglandin E2 (PGE2) has
a gastroprotective action against lesions caused by ethanol,
which is mainly associated with an increase in intracellular
guanosine-30,50-cyclicmonophosphate (cGMP), that is mediated
by an increase in intracellular free calcium concentration and
nitric oxide production (Sakai et al., 1995). In this study, the
analogue of PGE1, misoprostol, prevented the damage caused by
ethanol, conﬁrming the importance of PGs in the maintenance of
mucosal integrity.
Although pre-treatment with CCRE protects the gastric mucosa
against lesions induced by indomethacin, the effect was sup-
pressed when indomethacin was associated with ethanol, which
implies that the production of prostaglandins is an important
factor for protection of this extract. Our data suggest that Croton
campestris has gastroprotective effect mediated by NO and pros-
taglandins pathways. In contrast, our research group has pre-
viously shown that leaves of Croton campestris provide
gastroprotective action with involvement of NO pathway, but not
PGs pathway (Brito Júnior et al., 2013). These results are of high
ethnopharmacological relevance since people use infusions of
roots and leaves of this plant to treat gastric disorders.
Previous studies demonstrated that prostaglandins and NO coop-
erate with sensory nerves to the mechanism of gastric mucosal
integrity and cytoprotection (Brzozowski et al., 1999). Prostaglandins
also play an important role in modulating the integrity of the gastric
mucosa in the presence of gastric acid secretion through the
activation of KATP-channels (Curtis et al., 1995). In this contest, it
has been postulated that KATP channels are involved in a variety of
pathophysiological functions in the stomach, including regulation of
blood ﬂow, gastric acid secretion, and gastric muscle contractility
(Slomiany et al., 1985). These channels are related to the relaxation of
vascular smooth muscle, having an important role in blood pressure
control (Alqasoumi et al., 2008). Our study showed that CCRE, when
combined with glibenclamide, a sulfonylurea that blocks KATP
channels (Alqasoumi et al., 2008), the gastroprotector effect is
maintained, indicating that the protective effect of Croton campestris
was not mediated by stimulation of KATP channels.
α2-noradrenergic receptors are involved in the regulation of
gastric acid secretion and provides protection against chemical
agents such as NSAIDs and ethanol. The modulation of α2
receptors in peripheral parasympathetic ganglia intramural
reduces vagal discharge acetylcholine, which reduces the gastric
secretion and motility, and increases blood ﬂow (Yelken et al.,
1999). In the present study, administration of yohimbine, an
alkaloid that promotes neurotransmitter release by blocking pre-
synaptic α2 receptor did not reverse the protective effect of Croton
campestris against ethanol, pointing to a non involvement of these
receptors in the gastroprotective mechanism of Croton campestris.
An improved gastrointestinal motility could promote gastric
protection since it accelerates the gastric emptying of mucosa
aggressors. The gastrointestinal motility is primarily regulated by
cholinergic innervations of circular muscle layer of TGI, acting on
muscarinic receptors M1 and M3. Our results indicated that admin-
istration of Croton campestris did not alter the intestinal motility,
whereas, atropine, an inhibitor of muscarinic receptors does.
Bioactive chemical constituents of Croton campestris including
ﬂavonoids, terpenes, xanthones, saponins, alkaloids and tannins
have been shown to present gastroprotective potential (Morikawa
et al., 2006). Flavonoids protect the gastric mucosa against a
variety of ulcerogenic agents and in different mammalian species
(Mota et al., 2009). Several mechanisms of action may be involved
in the gastroproctective effects of these compounds including anti-
secretory, cytoprotective and antioxidant activity (Mota et al.,
2009). Quercetin has an anti-secretory mechanism of action
(Mota et al., 2009). This ﬂavonol has antihistaminic properties,
thus, decreasing histamine levels, as well as preventing the release
Fig. 9. The effect of CCRE on intestinal motility in mice. Signiﬁcance nnnpo0.001
versus C (vehicle control).
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of histamine from gastric mast cells and inhibiting the gastric
Hþ/Kþ proton pump, thereby, diminishing acid gastric secretion
(Kahraman et al., 2003). In addition, chalcones, in particular those
with more than one isoprenyloxyl group, possess cytoprotective
effects related with increasing of mucosal blood ﬂow, stimulation
of synthesis of muco in the gastric mucosa and increasing in PGs
levels (Mota et al., 2009).
The results of this study conﬁrm the gastroprotective activity of
roots of Croton campestris. This gastroprotection is mediated by a
mechanism of action involving the stimulation of NO and prosta-
glandins synthesis. In view of our results, further investigations will
help to provide insights about the role of active ﬂavonoids among
other compounds present in CCRE on the gastric protection.
5. Conclusion
In summary, we demonstrate for the ﬁrst time the gastropro-
tective potential of CCRE against gastric mucosal induced damage
by noxious agents such as ethanol, acidiﬁed ethanol and indo-
methacin. This was evidenced by its ability to inhibit gastric
lesions formation. Such effect seems to be mediated by stimulation
of endogenous prostaglandins and NO release that lead to an
increase in microcirculation. This effect could be attributed at
least, in part to the presence of a wide spectrum of ﬂavonoids and
the presence of other compounds. Taking together, our results
indicate that the used of Croton campestris in traditional Brazilian
medicine for the treatment of gastric disorders, has a scientiﬁc
basis. Therefore, CCRE should be seen as a promising source for the
development of novel therapeutic agent for the treatment of
gastropathies.
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